pubmed-article:17011449 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17011449 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:17011449 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
pubmed-article:17011449 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
pubmed-article:17011449 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
pubmed-article:17011449 | lifeskim:mentions | umls-concept:C0086960 | lld:lifeskim |
pubmed-article:17011449 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:17011449 | lifeskim:mentions | umls-concept:C0521115 | lld:lifeskim |
pubmed-article:17011449 | lifeskim:mentions | umls-concept:C2728259 | lld:lifeskim |
pubmed-article:17011449 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:17011449 | pubmed:dateCreated | 2006-10-2 | lld:pubmed |
pubmed-article:17011449 | pubmed:abstractText | Administration of gemcitabine together with cisplatin at cytotoxic doses in a chemoradiotherapy regimen is hampered by a high degree of local toxicity. Using the pharmacologic properties of the drug we designed a modified schedule aimed at reducing toxicity while preserving activity. | lld:pubmed |
pubmed-article:17011449 | pubmed:language | eng | lld:pubmed |
pubmed-article:17011449 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17011449 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17011449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17011449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17011449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17011449 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17011449 | pubmed:month | Nov | lld:pubmed |
pubmed-article:17011449 | pubmed:issn | 0360-3016 | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:NumicoGianmau... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:GranettoCrist... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:GarroneOrnell... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:GascoMilenaM | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:MerlanoMarcoM | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:RussiElvio... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:FeaElenaE | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:OccelliMarcel... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:Di... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:ColantonioIda... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:TagliantiRicc... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:PelisseroAnto... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:CipolatMarcoM | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:VitielloRaffe... | lld:pubmed |
pubmed-article:17011449 | pubmed:author | pubmed-author:SorrentinoRaf... | lld:pubmed |
pubmed-article:17011449 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17011449 | pubmed:day | 1 | lld:pubmed |
pubmed-article:17011449 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:17011449 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17011449 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17011449 | pubmed:pagination | 731-7 | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:meshHeading | pubmed-meshheading:17011449... | lld:pubmed |
pubmed-article:17011449 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:17011449 | pubmed:articleTitle | Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule. | lld:pubmed |
pubmed-article:17011449 | pubmed:affiliation | Medical Oncology, S. Croce General Hospital, Cuneo, Italy. gianmauro.numico@fastwebnet.it | lld:pubmed |
pubmed-article:17011449 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17011449 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17011449 | lld:pubmed |